查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589610

乾眼症市場：依藥物、產品分類 - 全球預測 2025-2030

Dry Eye Syndrome Market by Drug (Anti-inflammatory Drugs, Autologous Serum Eye Drops, Lubricant Eye Drops), Product (Eye Ointment, Gel, Liquid Drops) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

乾眼症市場2023年估值為43.9億美元，預計到2024年將達到47.1億美元，複合年成長率為7.21%，到2030年預計將達到71.6億美元。

乾眼症（DES）是一種多因素疾病，其特徵是淚液數量或品質缺乏，導致眼表發炎和損傷。乾眼症市場包括旨在減輕症狀和提高患者生活品質的診斷方法、藥物、設備和替代療法。由於人口老化、生活方式的改變和長時間接觸數位螢幕，全球盛行率不斷增加，對有效管理方案的需求變得越來越重要。最終用途範圍從人工淚液和複合藥物到穿刺塞和程序解決方案等醫療設備，服務消費者和臨床環境。關鍵的成長要素包括公眾對眼睛健康意識的提高、診斷技術的進步以及監管部門對新療法的核准迅速增加。最新的機會在於使用遠端醫療進行遠距離診斷和護理、個人化醫療方法的開拓以及未確診人群新興市場的擴張。要利用這些優勢，就需要對研發進行投資，與高科技公司合作以實現創新的交付機制，以及擴大進入範圍的策略定價模式。該市場面臨著巨大的潛力、嚴格的監管要求、高昂的研究成本以及管理與新療法相關的副作用等挑戰。此外，已開發國家的市場飽和和患者違規從也是主要障礙。對於尋求創新的公司來說，探索非侵入性診斷工具、人工智慧主導的患者管理系統以及眼部護理產品的永續生產呈現出良好的前景。這些細分市場不僅能帶來收益來源，也能提高病患的參與度和治療效果。整體而言，在醫療進步和消費者期望的推動下，市場充滿活力，需要發展策略的靈活性和遠見。相關人員必須跟上技術進步、不斷變化的法規和不斷變化的消費者偏好，以有效解決這個新興的健康問題。

主要市場統計
基準年[2023] 43.9億美元
預測年份 [2024] 47.1億美元
預測年份 [2030] 71.6億美元
複合年成長率（%） 7.21%

市場動態：揭示快速發展的乾眼症市場的關鍵市場洞察

供需的動態交互作用正在改變乾眼症市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 乾眼症盛行率增加
    • 提高乾眼診斷和治療意識
    • 世界老年人口的增加
  • 市場限制因素
    • 嚴格的監管流程
  • 市場機會
    • 新技術開發
    • 加大研發投入
  • 市場問題
    • 產品召回增加

波特五力：駕馭乾眼症市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解乾眼症市場的外在影響

外部宏觀環境因素在塑造乾眼症市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解乾眼症市場的競爭格局

乾眼症市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：乾眼症市場供應商的績效評估

FPNV 定位矩陣是評估乾眼症市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：制定乾眼症市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，乾眼症市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 乾眼症增加
      • 提高疾病診斷和治療意識
      • 世界各地人口老化仍在持續
    • 抑制因素
      • 嚴格的監管流程
    • 機會
      • 新技術開發
      • 加大研發投入
    • 任務
      • 產品召回增加
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章乾眼症市場：依藥品分類

  • 介紹
  • 發炎藥
  • 自體血清眼藥水
  • 潤滑眼藥水

第7章乾眼症市場：依產品

  • 介紹
  • 眼藥膏
  • 凝膠
  • 水滴
  • 液體擦拭巾

第8章北美和南美乾眼症市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太乾眼症市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲乾眼症市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • AFT Pharmaceuticals
  • Akorn Operating Company LLC
  • Alcon Vision LLC
  • Bausch & Lomb Pvt Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Mitotech SA
  • Nicox SA
  • Novartis AG
  • Otsuka Holdings Co
  • Prestige Consumer Healthcare
  • Santen Pharmaceutical Co.ltd
  • Sentiss Pharma Pvt. Ltd
  • Sun Pharmaceutical Industries Ltd
Product Code: MRR-4348D129FA98

The Dry Eye Syndrome Market was valued at USD 4.39 billion in 2023, expected to reach USD 4.71 billion in 2024, and is projected to grow at a CAGR of 7.21%, to USD 7.16 billion by 2030.

Dry Eye Syndrome (DES) is a multifactorial disease characterized by a deficiency in the quantity or quality of tears, leading to inflammation and damage to the ocular surface. The market for Dry Eye Syndrome encompasses diagnostic approaches, pharmaceuticals, devices, and alternative therapies aimed at alleviating symptoms and improving the quality of life for patients. With an increasing global prevalence, driven largely by ageing populations, lifestyle changes, and prolonged digital screen exposure, the necessity for effective management options grows ever more critical. Primary applications and end-uses range from artificial tears and prescription medications to medical devices like punctal plugs and procedural solutions, catering to both consumer and clinical settings. Key growth factors include rising public awareness about eye health, advancements in diagnostic technologies, and a surge in regulatory approvals for novel treatments. The latest opportunities lie in leveraging telehealth for remote diagnosis and care, developing personalized medicine approaches, and expanding markets in emerging regions with underdiagnosed populations. Successfully capitalizing on these requires investments in R&D, collaboration with tech companies for innovative delivery mechanisms, and strategic pricing models for broader access. Despite its potential, the market faces challenges, such as stringent regulatory requirements, substantial research costs, and side effect management associated with new treatments. Additionally, market saturation in developed countries and patient non-compliance pose significant obstacles. For businesses seeking innovation, exploring non-invasive diagnostic tools, AI-driven patient management systems, and sustainable production of eye-care products offer lucrative prospects. These areas promise not just revenue streams but also enhanced patient engagement and outcomes. Overall, the market is highly dynamic, driven by both medical advancements and consumer expectations, necessitating agility and foresight in development strategies. To thrive, stakeholders must stay abreast of technological progress, evolving regulations, and shifting consumer preferences to effectively address this burgeoning health concern.

KEY MARKET STATISTICS
Base Year [2023] USD 4.39 billion
Estimated Year [2024] USD 4.71 billion
Forecast Year [2030] USD 7.16 billion
CAGR (%) 7.21%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dry Eye Syndrome Market

The Dry Eye Syndrome Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of dry eye diseases
    • Growing awareness regarding diagnosis and treatment of the disease
    • Rising geriatric population across the world
  • Market Restraints
    • Stringent regulatory process
  • Market Opportunities
    • Development of novel technologies
    • Increase in R&D investment
  • Market Challenges
    • Increase in product recall

Porter's Five Forces: A Strategic Tool for Navigating the Dry Eye Syndrome Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dry Eye Syndrome Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dry Eye Syndrome Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dry Eye Syndrome Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dry Eye Syndrome Market

A detailed market share analysis in the Dry Eye Syndrome Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dry Eye Syndrome Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dry Eye Syndrome Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dry Eye Syndrome Market

A strategic analysis of the Dry Eye Syndrome Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dry Eye Syndrome Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AFT Pharmaceuticals, Akorn Operating Company LLC, Alcon Vision LLC, Bausch & Lomb Pvt Ltd., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Mitotech S.A., Nicox S.A., Novartis AG, Otsuka Holdings Co, Prestige Consumer Healthcare, Santen Pharmaceutical Co.ltd, Sentiss Pharma Pvt. Ltd, and Sun Pharmaceutical Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Dry Eye Syndrome Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug, market is studied across Anti-inflammatory Drugs, Autologous Serum Eye Drops, and Lubricant Eye Drops.
  • Based on Product, market is studied across Eye Ointment, Gel, Liquid Drops, and Liquid Wipes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of dry eye diseases
      • 5.1.1.2. Growing awareness regarding diagnosis and treatment of the disease
      • 5.1.1.3. Rising geriatric population across the world
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory process
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of novel technologies
      • 5.1.3.2. Increase in R&D investment
    • 5.1.4. Challenges
      • 5.1.4.1. Increase in product recall
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dry Eye Syndrome Market, by Drug

  • 6.1. Introduction
  • 6.2. Anti-inflammatory Drugs
  • 6.3. Autologous Serum Eye Drops
  • 6.4. Lubricant Eye Drops

7. Dry Eye Syndrome Market, by Product

  • 7.1. Introduction
  • 7.2. Eye Ointment
  • 7.3. Gel
  • 7.4. Liquid Drops
  • 7.5. Liquid Wipes

8. Americas Dry Eye Syndrome Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Dry Eye Syndrome Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Dry Eye Syndrome Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AFT Pharmaceuticals
  • 3. Akorn Operating Company LLC
  • 4. Alcon Vision LLC
  • 5. Bausch & Lomb Pvt Ltd.
  • 6. GlaxoSmithKline PLC
  • 7. Johnson & Johnson Services, Inc.
  • 8. Mitotech S.A.
  • 9. Nicox S.A.
  • 10. Novartis AG
  • 11. Otsuka Holdings Co
  • 12. Prestige Consumer Healthcare
  • 13. Santen Pharmaceutical Co.ltd
  • 14. Sentiss Pharma Pvt. Ltd
  • 15. Sun Pharmaceutical Industries Ltd

LIST OF FIGURES

  • FIGURE 1. DRY EYE SYNDROME MARKET RESEARCH PROCESS
  • FIGURE 2. DRY EYE SYNDROME MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRY EYE SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DRY EYE SYNDROME MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DRY EYE SYNDROME MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRY EYE SYNDROME MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRY EYE SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRY EYE SYNDROME MARKET DYNAMICS
  • TABLE 7. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY AUTOLOGOUS SERUM EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY LUBRICANT EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY EYE OINTMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY LIQUID DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY LIQUID WIPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. DRY EYE SYNDROME MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. DRY EYE SYNDROME MARKET, FPNV POSITIONING MATRIX, 2023